Revolution Medicines (RVMD) Interest & Investment Income (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Interest & Investment Income of $19.5 million for Q1 2026, down 21.7% year-over-year from $24.9 million in Q1 2025, and down 78.06% quarter-over-quarter from $88.9 million in Q4 2025.
Revolution Medicines (RVMD) Interest & Investment Income (2019 - 2026) Analysis & Trends
Revolution Medicines' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $19.5 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 21.7% year-over-year to $19.5 million; the TTM figure through Mar 2026 stood at $130.1 million (up 154.32% YoY), while the FY2025 annual figure was $90.7 million, up 4.39% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $19.5 million, down from $88.9 million in the prior quarter.
- The five-year high for Interest & Investment Income was $88.9 million in Q4 2025, with the low at -$1.8 million in Q4 2022.
- The 5-year median for Interest & Investment Income is $1.2 million (2023), against an average of $10.7 million.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income plunged 1613.21% in 2022, then jumped 1530.25% in 2025.
- Revolution Medicines' Interest & Investment Income stood at -$1.8 million in 2022, then soared by 180.72% to $1.4 million in 2023, then surged by 1400.0% to $21.2 million in 2024, then soared by 318.84% to $88.9 million in 2025, then slumped by 78.06% to $19.5 million in 2026.
- Business Quant data shows RVMD's Interest & Investment Income at $19.5 million in Q1 2026, $88.9 million in Q4 2025, and $22.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 36.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.58 Mn |
| Mar 31, 2026 | 19.51 Mn |
| Dec 31, 2025 | 88.90 Mn |
| Sep 30, 2025 | 22.08 Mn |
| Jun 30, 2025 | -405,000.00 |
| Mar 31, 2025 | 24.92 Mn |
| Dec 31, 2024 | 21.23 Mn |
| Sep 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | -665,000.00 |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 380,000.00 |
| Jun 30, 2023 | -695,000.00 |
| Mar 31, 2023 | 1.22 Mn |
| Dec 31, 2022 | -1.75 Mn |
| Sep 30, 2022 | 2.91 Mn |
| Jun 30, 2022 | -481,000.00 |
| Mar 31, 2022 | -908,000.00 |
| Dec 31, 2021 | -1.18 Mn |
| Sep 30, 2021 | 223,000.00 |